Mizuho’s Jared Holz on Merck and Pfizer This autumn outcomes, 2025 outlook for Massive Pharma shares

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Field’ to interrupt down the quarterly earnings outcomes of Merck and Pfizer, 2025 outlook for pharmaceutical shares, and extra.